Phase I trials involving radiation therapy, quantifying the risks

Targeted therapy-induced radiation recall

(2013) Antonin Levy et al.   EUROPEAN JOURNAL OF CANCER

Pulmonary Toxicity After Bevacizumab and Concurrent Thoracic Radiotherapy Observed in a Phase I Study for Inoperable Stage III Non–Small-Cell Lung Cancer

(2012) Joline S.W. Lind et al.   JOURNAL OF CLINICAL ONCOLOGY

NCI–RTOG Translational Program Strategic Guidelines for the Early-Stage Development of Radiosensitizers

(2012) Yaacov Richard Lawrence et al.   JNCI-Journal of the National Cancer Institute

Radiation Recall Pneumonitis Caused by Erlotinib after Palliative Definitive Radiotherapy

(2012) Cem Onal et al.   ONKOLOGIE

Two cases of gastrointestinal perforation after radiotherapy in patients receiving tyrosine kinase inhibitor for advanced renal cell carcinoma

(2012) Takaaki Inoue et al.   World Journal of Surgical Oncology

Exacerbation of radiation fibrosis with erlotinib: another pattern of radiation recall phenomenon

(2011) Hiroaki Arakawa et al.   JAPANESE JOURNAL OF RADIOLOGY

Acute toxicity of second generation HIV protease-inhibitors in combination with radiotherapy: a retrospective case series

(2011) Alfred P See et al.   Radiation Oncology

Gastrointestinal toxicity of vorinostat: reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapy

(2011) Åse Bratland et al.   Radiation Oncology

Phase I Oncology Studies: Evidence That in the Era of Targeted Therapies Patients on Lower Doses Do Not Fare Worse

(2010) R. K. Jain et al.   CLINICAL CANCER RESEARCH

Unexpected late radiation neurotoxicity following bevacizumab use: a case series

(2010) Paul J. Kelly et al.   JOURNAL OF NEURO-ONCOLOGY

Tracheoesophageal Fistula Associated with Bevacizumab 21 Months after Completion of Radiation Therapy

(2010) Elizabeth Gore et al.   Journal of Thoracic Oncology

Tracheoesophageal Fistula Formation in Patients With Lung Cancer Treated With Chemoradiation and Bevacizumab

(2009) David R. Spigel et al.   JOURNAL OF CLINICAL ONCOLOGY

High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: Results of a survey in EORTC institutes

(2008) Christian Giro et al.   RADIOTHERAPY AND ONCOLOGY